Kristen F Milne, MD in Bellevue, WA - Emergency Medicine

Kristen F Milne, MD is a Emergency Medicine physician based in Bellevue, Washington. Kristen F Milne is licensed to practice in Washington (license number 35915) and her current practice location is 1035 116th Avenue Ne, Bellevue, Washington. She can be reached at her office (for appointments etc.) via phone at (425) 688-5759.

NPI number for Kristen F Milne is 1235232240 and her current mailing address is Po Box 34960, Seattle, Washington. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1235232240.

Contact Information

	Kristen F Milne, MD
	1035 116th Avenue Ne, Bellevue, WA 98004
	(425) 688-5759
	(425) 688-5101

Physician's Profile

Full Name	Kristen F Milne
Gender	Female
Speciality	Emergency Medicine
Location	1035 116th Avenue Ne, Bellevue, Washington
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1235232240
Provider Enumeration Date: 09/06/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Kristen F Milne such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1235232240	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207P00000X	Emergency Medicine	35915 (Washington)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kristen F Milne is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Kristen F Milne, MD Po Box 34960, Seattle, WA 98124-1960 Ph: (425) 688-5759	Kristen F Milne, MD 1035 116th Avenue Ne, Bellevue, WA 98004 Ph: (425) 688-5759

News Archive

New antibody can be used as early diagnostic tool for Parkinson's

Conditions such as Parkinson's disease are a result of pathogenic changes to proteins. In the neurodegenerative condition of Parkinson's disease, which is currently incurable, the alpha-synuclein protein changes and becomes pathological. Until now, there have not been any antibodies that could help to demonstrate the change in alpha-synuclein associated with the disease. An international team of experts led by Gabor G. Kovacs from the Clinical Institute of Neurology at the MedUni Vienna has now discovered a new antibody that actually possesses this ability.

Research reveals balancing act between sugar-coated nanoparticles

A research team at the National Institute of Standards and Technology (NIST) studying sugar-coated nanoparticles for use as a possible cancer therapy has uncovered a delicate balancing act that makes the particles more effective than conventional thinking says they should be. Just like individuals in a crowd respecting other people's personal space, the particles work because they get close together, but not too close.

Research pinpoints new therapeutic opportunity for ovarian clear cell carcinomas

Mutations in the ARID1A gene are present in more than 50% of ovarian clear cell carcinomas (OCCC), for which effective treatments are lacking. Scientists at The Wistar Institute discovered that loss of ARID1A function enhances a cellular stress response pathway that promotes survival of cancer cells, which become sensitive to pharmacological inhibition of this pathway. These findings were published online in Cancer Research, a journal of the American Association for Cancer Research, and point to a new therapeutic opportunity for this type of ovarian cancer for which new solutions are urgently needed.

Patients can have misguided view of asthma

Over half of adults with serious asthma believe they only have asthma when they have symptoms and these individuals are significantly less likely to take necessary medications during asymptomatic periods, according to a study in the March issue of Chest.

Better understanding of cells' development has implications in study of inflammatory diseases

Labs around the world, and a core group at Penn, have been studying recently described populations of immune cells called innate lymphoid cells. Some researchers liken them to foot soldiers that protect boundary tissues such as the skin, the lining of the lung, and the lining of the gut from microbial onslaught. They also have shown they play a role in inflammatory disease, when the body's immune system is too active.

Emergency Medicine Doctors in Bellevue, WA

Dr. Stephen I Tilghman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 15325 Se 30th Pl Ste 200, Bellevue, WA 98007 Phone: 425-641-4451 Fax: 425-641-7640
Salma F Gharib, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000
Stephen W Marshall, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1035 116th Avenue Ne, Bellevue, WA 98004 Phone: 425-688-5759 Fax: 425-688-5101
Marcus A Trione, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1035 116th Avenue Ne, Bellevue, WA 98004 Phone: 425-688-5759 Fax: 425-688-5101
Dr. Lawrence Chu, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5623 168th Pl Se, Bellevue, WA 98006 Phone: 425-746-3515
Cory Heidelberger, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1035 116th Ave Ne, Bellevue, WA 98004 Phone: 425-688-5759
Dr. Benjamin Andrew Savitch, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1035 116th Ave Ne, Bellevue, WA 98004 Phone: 425-688-5759

Kristen F Milne, MD - Emergency Medicine in Bellevue, WA